CSPG4P13: A Drug Target / Disease Biomarker (G100302666)

Target Name: CSPG4P13

NCBI ID: G100302666

Other Name(s): Chondroitin sulfate proteoglycan 4 pseudogene 13 | chondroitin sulfate proteoglycan 4 pseudogene 13

CSPG4P13: A Drug Target / Disease Biomarker

CSPG4P13 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the CSPG4 family, which is known for its role in intracellular signaling. CSPG4P13 has been shown to play a role in a variety of biological processes, including the regulation of ion channels, cell signaling, and inflammation. As a result, CSPG4P13 has potential as a drug target or biomarker.

One of the key functions of CSPG4P13 is its role in intracellular signaling. CSPG4P13 is a protein that can interact with a variety of intracellular signaling molecules, including ion channels, tyrosines, and chemokines. It has been shown to play a role in regulating the activity of these molecules, which can affect a wide range of cellular processes, including cell signaling, cell division, and inflammation.

CSPG4P13 has also been shown to be involved in the regulation of ion channels. These channels are responsible for the movement of charged particles, such as ions, through the cell membrane. The regulation of ion channels is critical for the proper functioning of many cellular processes, including muscle contractions, nerve signaling, and the regulation of pH levels. CSPG4P13 has been shown to play a role in regulating the activity of ion channels, which can affect the movement of ions through the membrane.

In addition to its role in intracellular signaling, CSPG4P13 has also been shown to be involved in the regulation of cell signaling. CSPG4P13 can interact with a variety of signaling molecules, including tyrosines, which are proteins that can bind to and activate intracellular signaling systems. This interaction between CSPG4P13 and tyrosines can affect the activity of these molecules, which can lead to changes in cellular behavior.

CSPG4P13 is also involved in the regulation of inflammation. Many diseases, including cancer, are characterized by the activation and proliferation of immune cells, which can lead to inflammation. CSPG4P13 has been shown to play a role in the regulation of inflammation, as it can affect the activity of immune cells and the production of pro-inflammatory molecules.

As a result of its involvement in intracellular signaling, CSPG4P13 has potential as a drug target or biomarker. Many diseases, including cancer, are characterized by the activation and proliferation of immune cells, which can lead to inflammation. By targeting CSPG4P13, researchers may be able to develop new treatments for these diseases. Additionally, CSPG4P13 may also be used as a biomarker to diagnose and monitor diseases.

In conclusion, CSPG4P13 is a protein that is involved in a variety of biological processes, including intracellular signaling, ion channels, cell signaling, and inflammation. As a result, CSPG4P13 has potential as a drug target or biomarker. Further research is needed to fully understand the role of CSPG4P13 in these processes and to develop new treatments for diseases associated with its dysfunction.

Protein Name: Chondroitin Sulfate Proteoglycan 4 Pseudogene 13

More Common Targets